<DOC>
	<DOC>NCT00490269</DOC>
	<brief_summary>This study will examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant drug interactions before conducting outpatient studies.</brief_summary>
	<brief_title>Ph1 Marinol Interaction Study - Part 2 - 1</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Must be between 18 and 45 years of age Must be in good general health and who meet DSMIV diagnostic criteria for marijuana dependence Must be seeking treatment at time of study entry Must be able to understand and provide written informed consent Must provide 1 marijuana positive urine specimen (&gt; 50 ng/mL) within the 28day screening period If female and of child bearing potential, agrees to use birth control. Exclusion Criteria: Please contact site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Marijuana dependence</keyword>
</DOC>